摘要 |
<p>The present invention relates to compounds of the formula (I) wherein R<1>, R<2>, R<3>, R<4>, R<5>, R<7>, and L are as described in the specification. The present invention also relates to pharmaceutical compositions that include compounds of the formula (I) and a pharmaceutically acceptable carrier. Moreover, the present invention relates to methods of using the above-described compounds and compositions to treat and prevent diseases and conditions including those that may be treated or prevented by antagonizing the CCR1 receptor.</p> |
申请人 |
PFIZER PRODUCTS INC.;BROWN, MATTHEW, FRANK;GAWECO, ANDERSON, SEE;GLADUE, RONALD, PAUL;KATH, JOHN, CHARLES;POSS, CHRISTOPHER, STANLEY |
发明人 |
BROWN, MATTHEW, FRANK;GAWECO, ANDERSON, SEE;GLADUE, RONALD, PAUL;KATH, JOHN, CHARLES;POSS, CHRISTOPHER, STANLEY |